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Identity 
Other names: NFAT1, NFATP 




The NFATC2 gene consists of 11 exons of which the 
last is the biggest. There are five known transcripts, 
varying from 7525 to 620 base pairs of  
which the largest four lead to a protein product 
(ensembl, last viewed at 10-04-2012) (Macian, 2005). 
Transcription 
Transcription of the gene is from the - strand. 
Transcribed sequence contains both a 5'and a 3'-UTR 
region.  
The 5-UTR is located in exon 10 and the full exon 11 
and is > 4500 bases in size. The large UTR indicates 
transcription control by small non-coding RNA and/or 
large non-coding RNA sequences (ensembl, last 
viewed at 10-04-2012). 
 
Figure 1: Genomic organization of NFATC2. The NFATC2 gene is localized on the minus (-) strand of the 20q13.2 chromosome. Black 
boxes resemble untranslated regions (UTR's); colors of translated exons correspond to protein domains (see later); boxe sizes are in 
proportion to exon size. 
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Figure 2: The NFATC2 protein. NHR, NFAT homology region; RHR, REL-homology region; NLS, nuclear localization signal; SRR, 




NFATc2 is part of the NFAT family of transcription 
factors. The conserved region of all NFAT proteins 
consists of two domains. The first is the NFAT 
Homology region (NHR) which is the regulatory 
domain. It contains a strong transactivation domain and 
many serine residues that are phosphorylated when the 
protein is inactive and resides in the cytoplasm. There 
are two serine rich regions (SRRs) and three SPXX-
repeat motifs (SPs), where X stands for any amino acid. 
Calcineurin and NFAT kinases regulate the activity of 
the NFAT proteins by determining the phosphorylation 
status of the serine residues, interacting with NFAT 
proteins at the NHR. 
Another, highly conserved region of the NFAT family 
is the DNA binding domain that is structurally relat d 
to the DNA binding domain of the Rel-Family of 
transcription factors. This domain, called the REL 
homology region (RHR) is also responsible for binding 
partner proteins like the AP1 complex. 
There are three alternative splice variants of the 
NFATC2 protein, all of which occur in the C-terminal 
domain of the protein (Macian, 2005). 
Expression 
Inactive NFATC2 normally resides in the cytoplasm 
where the serine residues in the NHR are 
phosphorylated. This phosphorylated state of the NHR 
results in configuration changes of the protein shielding 
the nuclear localisation signal (NLS). Activation of
NFATC2 is regulated by a pathway including calcium 
influx to the cytoplasm, calmodulin and calcineurin. I  
response to various stimuli, calcium enters the 
cytoplasm from the environment and intracellular 
stores. Calcium binds calmodulin and this complex 
activates calcineurin. The activated calcineurin will 
dephosphorylate the SRRs and SPs of the NHR, 
resulting in the exposure of the NLS and translocati n 
of the protein to the nucleus. Translocated NFAT binds  
 
to consensus DNA sites (WGGAAANHN (H is not G,  
N is any of the four nucleotides)) and control gene 
transcription with the help of other nuclear complexes 
such as the AP1 protein complex (Macian, 2005). 
Several kinases have been identified to rephosphorylate 
NFAT proteins at multiple sites, thereby controlling 
their nuclear shuttling. These kinases include glycogen-
synthase kinase 3 (GSK3), casein kinase 1 (CK1), p38
and JUN N-terminal kinase (JNK).  
Some of them act as maintenance kinases, to keep th 
NFAT proteins in the cytosol in a fully phosphorylated 
state, preventing them from nuclear shuttling. Others 
act as export kinases; they rephosphorylate NFAT in 
the nucleus and thereby promote the nuclear export of 
NFAT, stopping the NFAT driven transcription after 
calcineurin activity declines. 
Another regulatory mechanism has been discovered for 
NFAT proteins which uses a non-coding RNA 
(ncRNA). Functional analysis of ncRNAs found a Non-
coding repressor of NFAT (NRON). When NRON was 
deactivated by small hairpin RNA (shRNA), a dramatic 
increase in NFAT activity was measured. NRON 
directly binds to 11 proteins, of which four are 
repressors of NFAT.  
NRON probably interacts with the nuclear shuttling of 
NFAT proteins which is demonstrated by an increase in 
nuclear localisation upon treatment with NRON 
shRNA (Rao et al., 1997; Willingham et al., 2005; 
Macian, 2005). 
At this moment, 8 different microRNA's, which target 
5 locations on the NFATC2 gene have been discovered 
(ensembl last viewed at 10-04-2012). 
Localisation 
In its inactive form, NFATC2 resides in the cytoplasm.  
When activated it translocates to the nucleus (Macian, 
2005). 
Function 
NFATC2 is a transcription factor that forms complexes 
with other nuclear proteins including the AP-1 complex 
and regulates transcription of a large number of genes.  
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Figure 3: Translocation at DNA level. Numbers correspond to exon numbers; black regions are untranslated regions; box sizes are in 
proportion to exon size; colors correspond to protein domains. 
 
It thereby regulates many processes including cell 
differentiation, migration and angiogenesis. It is, 
together with the other NFAT's, essential for the 
development of multiple organ systems, including the
nerve and immune system, the heart and skeletal 
muscles, the vasculature, the lungs and the skeletal 
structures. Because of their multiple functions, 
dysfunction of NFAT's may play a role in pathobiology 
of cancer (Wu et al., 2007; Macian, 2005). 
Homology 
NFATC2 shows great similarity with the NFATC1, 
NFATC3 and NFATC4 proteins. The RHR shows great 
similarity with the DNA binding sites of proteins of the 
REL family of transcription factors (Hogan et al., 
2003). 
Implicated in 
Ewing sarcomalike small blue round 
cell tumour 
Note 
The NFATC2 gene was found to be involved in a 
chromosomal translocation found in an Ewing 
sarcomalike small blue round cell tumour. In this 
entity, the EWSR1 gene is fused in frame with the 
NFATC2 gene resulting in a chimera gene. In addition, 
an amplification of the chimera gene has been 
observed, something that hasn't been seen in other 
EWSR1 gene translocation tumours (Szuhai et al., 
2007; Szuhai et al., 2009). 
Abnormal protein 
In the chimera protein, the regulatory domain of the
EWSR1 protein is fused with the functional domain of 
the NFATC2 gene. EWSR1 is a member of the TET 
family of proteins and has a predominantly  
nuclear localization. It contains a domain for nucleic 
acid binding and has, among others a function in RNA 
polymerase II- mediated transcription and premRNA 
splicing. In the chimera protein, the N-terminal 
regulatory domain of NFATC2 is completely replaced 
by the regulatory domain of the EWSR1 protein. In this
way, the localization of the NFATC2 containing 
chimera is not under the control of the Ca2+ dependent 
calcineurin/calmodulin phosphorylation. Instead, the 
chimera gains the strong, highly conserved NLS of 
EWSR1 which leads to uncontrolled shuttling of the 
chimera to the nucleus. Also, because the transcription 
of the chimera is under control of the regulatory 
domain of EWSR1, the regulatory loop of NFATC2 is 
abrogated. The RHR of NFATC2, which is responsible 
for DNA binding and the complex formation with other 
proteins such as the AP-1 complex is completely 
retained in the chimera (Szuhai et al., 2009; Tan et al., 
2009). 
Oncogenesis 
Some homology can be seen between this recently 
described small blue round cell tumour and Ewing 
sarcoma. In Ewing Sarcoma, the EWSR1 gene forms a 
chimera with members of the ETS family. In this 
entity, the member of the ETS family is replaced by 
NFATC2. The consensus sequence for the ETS family 
contains a core domain of GGAW (W is a wobble for 
A or T), whereas the conserved core domain for NFAT 
is WGGAAANHN (H is not G, N is any of the four 
nucleotides).  
There is complete overlap between the core domain of 
ETS and NFAT for the GGAA sequence variant, which 
might be responsible for the similar histological 
features of tumors despite the involvement of different 
transcription factor families. 
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Figure 4: Translocation at protein level. Yellow box corresponds to nuclear localisation signal. 
 
 
Both ETS family members, the EWS/FLI chimera and 
NFATC2 form complexes with AP-1.  
It has yet to be determined whether the 
EWSR1/NFATC2 chimera does this as well (Szuhai et 
al., 2009; Sankar et al., 2011). 
Non small cell lung cancer 
Note 
The expression of NFATC2 in non small cell lung 
cancer is positively correlated with progression in 
TNM stage: the higher the TNM stage, the higher the 
expression of NFATC2.  
High expression of NFATC2 is also a predictor for a 
low post-operative survival indicating that it promtes 
lung cancer and metastasis by serving as an oncogene 
(Chen et al., 2011). 
Breast cancer 
Note 
Stat 5 signalling.  
Stat5, a member of the signal transducers and activators 
of transcription (stat) family of proteins, promotes 
tumor growth, but suppresses metastasis in breast 
cancer.  
NFATC2 has exactly the opposite effects; it inhibits 
tumor growth and promotes tumor metastasis. 
NFATC2 down regulates the Stat5 signaling pathway 
and vice versa.  
Also, the expression of the two genes is negatively 
correlated in a breast cancer progression tissue micro 
array (TMA). NFATC2 is expressed more in metastatic 
tissue than in normal tissue and primary tumor but 
Stat5 is the other way around (Zheng et al., 2011). 
Various cancers 
Note 
Regulation of tissue micro environment.  
Experiments in mice have been performed to assess th  
influence of NFATC2 on metastasis formation and 
growth.  
Therefore NFATC2 null(-/-) mice were compared with 
NFATC2 normal(+/+) mice after intravenous injection 
of F16F10 melanoma cells. NFATC2-/- mice showed 
less and smaller metastases.  
Both the NFATC2 null(-/-) and wild type mice were 
treated with a wild type bone marrow transplantation  
make sure differences were caused by the lack of 
NFATC2 in the lung parenchyma and not because of a 
dysfunction of the immune system (Werneck et al., 
2011).  
In hepatocellular carcinoma, colon carcinoma and 
breast cancer, NFATC2 plays an important role in 
regulating genes that affect tumoral phenotype such as 
cyclooxygenase-2 (COX-2). COX-2 is a key regulator 
in the expression of matrix metalloproteinase 1 and 
matrix metalloproteinase 2 and thereby of tumour 
invasion (Lara-Pezzi et al., 2002; Duque et al., 2005; 
Yiu et al., 2006). 
α6β4 integrin signalling 
Note 
NFAT signalling (including NFATC2 signalling) is 
part of the pathway that is activated in α6β4 integrin 
mediated cell invasion and migration.  
This pathway leads to the expression of autotoxin. It is 
suggested that α6β4 integrin mediated cell invasion is 
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at least in part due to the increased expression of 
autotoxin (Jauliac et al., 2002; Chen et al., 2005). 
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